Pu You
Overview
Explore the profile of Pu You including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
405
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li K, Shi H, Li Z, You P, Pan J, Cai Y, et al.
Cell Discov
. 2025 Feb;
11(1):12.
PMID: 39929796
No abstract available.
2.
Tang Q, Yuan Y, Li L, Xu Y, Ji W, Xiao S, et al.
Comput Biol Med
. 2024 Apr;
174:108457.
PMID: 38599071
Glioma is a common malignant brain tumor with great heterogeneity and huge difference in clinical outcomes. Although lymphotoxin (LT) beta receptor (LTBR) has been linked to immune system and response...
3.
Hou W, Cai J, Shen P, Zhang S, Xiao S, You P, et al.
Cancer Med
. 2023 Dec;
12(24):22170-22184.
PMID: 38093622
Objective: As a single-transmembrane protein of the FXYD family, FXYD6 plays different roles under physiological and pathological status, especially in the nervous system. This study aims to identify FXYD6 as...
4.
Liao R, You P, Weng K, Li L, Song Y
Anal Chem
. 2023 Jul;
95(28):10595-10602.
PMID: 37403445
Tandem mass tags (TMT) are one of the most widely used techniques in proteomics quantification due to their ability to accurately and precisely analyze up to 18 samples in a...
5.
Wang J, Zhu H, You P, Liu H, Wang W, Fan X, et al.
J Clin Invest
. 2022 Mar;
132(8).
PMID: 35239512
Y-box-binding protein 1 (YB-1) is a multifunctional RNA binding protein involved in virtually every step of RNA metabolism. However, the functions and mechanisms of YB-1 in one of the most...
6.
Cai Y, Fu Y, Liu C, Wang X, You P, Li X, et al.
Cell Death Dis
. 2022 Feb;
13(2):176.
PMID: 35210426
Microvascular invasion (MVI) is presently evaluated as a high-risk factor to be directly relative to postoperative prognosis of hepatocellular carcinoma (HCC). Up to now, diagnosis of MVI mainly depends on...
7.
Jiao X, Qin B, You P, Cai J, Zang Y
Lung Cancer
. 2018 Aug;
123:70-75.
PMID: 30089598
Objectives: The prognostic value of TP53 in advanced non-small-cell lung cancer (NSCLC) is unclear. Whether different mutated exon has different prognostic value is unknown. We sought to reveal the prognostic...
8.
Wang H, Fang Y, You P, Bao X, Li K, Yao J, et al.
Undersea Hyperb Med
. 2018 Jul;
45(3):351-362.
PMID: 30028921
Nuclear factor kappa B (NF-κB) is the critical transcriptional factor in the pathogenesis of acute lung injury (ALI). NF-κB regulates the expression changes of inflammatory factors such as tumor necrosis...
9.
Wang C, Chen W, Wu Y, You P, Zheng S, Liu C, et al.
Cell Death Dis
. 2018 May;
9(5):575.
PMID: 29760381
It is well known that induction of hepatocyte senescence could inhibit the development of hepatocellular carcinoma (HCC). Until now, it is still unclear how the degree of liver injury dictates...
10.
Bao X, Mao A, Fang Y, Fan Y, Wang F, Ma J, et al.
Am J Physiol Lung Cell Mol Physiol
. 2017 Oct;
314(2):L287-L297.
PMID: 29074491
Statins, which are 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase competitive inhibitors, not only lower blood cholesterol but also exert pleiotropic and beneficial effects in various diseases. However, the effects of statins...